Today: 7 February 2026
Subscribe
Browse Category

Investment Analysis News 8 December 2025

Micron Technology (MU) Surges After the Bell on December 8, 2025: AI Memory Boom, Price Target Hikes and What to Watch Before the December 9 Open

Micron Technology (MU) Surges After the Bell on December 8, 2025: AI Memory Boom, Price Target Hikes and What to Watch Before the December 9 Open

Published: December 9, 2025 – For informational purposes only; not investment advice. Micron rallies into the close — and keeps climbing after hours Micron Technology, Inc. (NASDAQ: MU) extended its powerful 2025 rally on Monday, December 8, as Wall Street doubled down on the AI-memory story driving the stock. MarketWatch highlighted that Micron “outperformed competitors on a strong trading day”, even as major indices struggled, underscoring how the AI-memory theme is overshadowing broader market jitters. MarketWatch With futures pointing to another volatile day, here’s what drove Monday’s move — and what investors should know heading into the December 9, 2025
8 December 2025
·····
Cisco Stock (CSCO) Today: AI Infrastructure Boom, Splunk Synergies and Fresh Analyst Upgrades Push Shares Toward 52‑Week Highs

Cisco Stock (CSCO) Today: AI Infrastructure Boom, Splunk Synergies and Fresh Analyst Upgrades Push Shares Toward 52‑Week Highs

Published: December 8, 2025 Cisco Systems, Inc. (NASDAQ: CSCO) is ending 2025 as one of the quieter winners of the AI infrastructure boom. After a year of rising AI‑driven networking orders and the full integration of its $28 billion Splunk acquisition, the networking giant has raised its long‑term outlook, drawn a wave of bullish research, and pushed its share price close to fresh 52‑week highs. Reuters+1 Below is a deep dive into where Cisco stock stands today, what the latest earnings and AI guidance tell us, how Wall Street is valuing CSCO, and the key risks investors are weighing. Cisco
8 December 2025
······
Accenture (ACN) Stock on 8 December 2025: OpenAI Deal, AI Pivot and 2026 Outlook Explained

Accenture (ACN) Stock on 8 December 2025: OpenAI Deal, AI Pivot and 2026 Outlook Explained

Accenture plc (NYSE: ACN) heads into mid‑December 2025 as one of the most closely watched “AI infrastructure” plays in global consulting. After a sharp de‑rating over the past year, the stock now trades around the mid‑$260s, roughly one‑third below its 52‑week high, even as the company posts solid growth, boosts its dividend and doubles down on generative AI partnerships with OpenAI, Snowflake and a growing stable of startups. Accenture Newsroom+3StockAnalysis+3Reuters+3 Below is a detailed look at the latest news, forecasts and analyses as of 8 December 2025, and what they may mean for Accenture shareholders and watchers. This article is
8 December 2025
·····
D‑Wave Quantum (QBTS) Stock Today – December 8, 2025: Government Pivot, Qubits 2026 and Bubble Fears

D‑Wave Quantum (QBTS) Stock Today – December 8, 2025: Government Pivot, Qubits 2026 and Bubble Fears

Snapshot: D‑Wave Quantum stock on December 8, 2025 As of the close on Monday, December 8, 2025, D‑Wave Quantum Inc. (NYSE: QBTS) remains one of the most volatile AI–adjacent names on the market. Key stats today According to TipRanks, QBTS has climbed more than 220% year‑to‑date in 2025 after starting the year in the single digits, even though the stock has sold off sharply from a peak near $40–$47. TipRanks+1 At the same time, the stock remains a battleground: All of this sits on top of a flood of new corporate news, bullish analyst upgrades, and loud warnings that quantum
8 December 2025
····
IBM vs Microsoft Stock in December 2025: Which AI Powerhouse Looks Like the Better Buy After IBM’s $11 Billion Confluent Deal?

IBM vs Microsoft Stock in December 2025: Which AI Powerhouse Looks Like the Better Buy After IBM’s $11 Billion Confluent Deal?

Published: December 8, 2025 – data and prices cited are as of intraday trading on this date. Key takeaways Market snapshot on December 8, 2025 As of late trading on December 8, 2025: Meanwhile, broader markets are trading cautiously as investors wait for this week’s Federal Reserve decision, keeping macro conditions in focus for both tech heavyweights. Investopedia+1 Today’s big story: IBM goes all‑in on data streaming with Confluent The headline driver for IBM stock on December 8, 2025 is clear: IBM has agreed to acquire Confluent in an $11 billion all‑cash deal at $31 per share, a roughly 34% premium to the target’s last close. Reuters+3IBM Newsroom+3Financial Times+3 What
8 December 2025
·····
Nebius Group N.V. (NBIS) Stock on December 8, 2025: Latest News, Price Targets and AI Cloud Growth Forecasts

Nebius Group N.V. (NBIS) Stock on December 8, 2025: Latest News, Price Targets and AI Cloud Growth Forecasts

Nebius Group N.V. (NASDAQ: NBIS) – the Amsterdam‑based AI infrastructure company spun out of Yandex – remains one of the most closely watched AI cloud stocks going into 2026. On December 8, 2025, the story is being driven by fresh institutional buying, new analyst coverage, and ongoing debate about whether its multi‑billion‑dollar AI contracts justify today’s rich valuation. Key takeaways for December 8, 2025 This article is for information and news purposes only and does not constitute financial advice. What exactly is Nebius Group? Nebius Group N.V. is a Dutch technology company headquartered in Amsterdam that provides full‑stack AI infrastructure
8 December 2025
·····
Fluence Energy (FLNC) Stock Today: Downgrades Hit High-Flying Battery Storage Play – Latest News, Price Targets and Forecasts

Fluence Energy (FLNC) Stock Today: Downgrades Hit High-Flying Battery Storage Play – Latest News, Price Targets and Forecasts

On December 8, 2025, Fluence Energy, Inc. (NASDAQ: FLNC) is giving investors a live lesson in volatility. After a huge rally over the past two weeks, the grid‑scale battery and software specialist is trading around $22–23 per share, down roughly 7–8% intraday as fresh analyst downgrades collide with strong growth guidance and a new UK battery storage milestone. The stock is still up more than 30% year‑to‑date and sits close to its one‑year high in the mid‑$20s, after climbing from a 12‑month low near $3.50. Finviz+1 Key takeaways for December 8, 2025 Below is a detailed look at the latest
8 December 2025
·····
Marvell Technology (MRVL) Stock Tumbles on Amazon and Microsoft Fears as AI Growth Story Gets Re‑Priced

Marvell Technology (MRVL) Stock Tumbles on Amazon and Microsoft Fears as AI Growth Story Gets Re‑Priced

Updated: December 8, 2025 Marvell Technology, Inc. (NASDAQ: MRVL) just got a harsh reminder that being an “AI infrastructure winner” doesn’t make you invincible. On Monday, December 8, Marvell stock fell sharply after a high‑profile analyst downgrade tied to possible custom‑chip design losses at Amazon Web Services and fresh worries that Microsoft may shift some custom silicon work to Broadcom. Intraday, MRVL dropped more than 10% before recovering part of the loss, trading in a roughly $88.9–$92.6 range — about 7% below Friday’s close of $98.91.StockAnalysis+2Investing.com+2 Paradoxically, on the very same day, Zacks upgraded Marvell to its top “Strong Buy”
8 December 2025
·····
Legend Biotech (LEGN) Stock Hits 52‑Week Low After UBS Cut: December 8, 2025 News, Outlook and Forecast

Legend Biotech (LEGN) Stock Hits 52‑Week Low After UBS Cut: December 8, 2025 News, Outlook and Forecast

Legend Biotech Corp. (NASDAQ: LEGN) shares are under heavy pressure on December 8, 2025, trading in the mid‑$20s and touching a new 52‑week low around $25.66 during the session. The slide comes despite strong clinical momentum for its flagship CAR‑T therapy CARVYKTI® and robust revenue growth, as investors react to valuation resets and ongoing concerns about profitability and cash flow. Investing.com+1 This article rounds up the key news and analysis on Legend Biotech stock from December 8, 2025 and the days immediately preceding it, and looks at what Wall Street expects next for LEGN. Disclaimer: This article is for information
8 December 2025
·····
Nurix Therapeutics (NRIX) Stock Soars on ASH 2025 Trial Data: Latest News, Analyst Forecasts and Outlook as of December 8, 2025

Nurix Therapeutics (NRIX) Stock Soars on ASH 2025 Trial Data: Latest News, Analyst Forecasts and Outlook as of December 8, 2025

Nurix Therapeutics, Inc. (NASDAQ: NRIX) is back in the spotlight. On December 8, 2025, the biotech stock surged roughly 20% intraday after the company released new Phase 1 data for its Bruton’s tyrosine kinase (BTK) degrader bexobrutideg (NX‑5948) in blood cancers at the American Society of Hematology (ASH) Annual Meeting and scheduled a corporate webcast for this evening. MarketBeat+3GlobeNewswire+3GlobeNewswire+3 The rally comes barely two months after Nurix posted a weak third quarter and executed a large equity raise, underscoring how heavily sentiment in this name is tied to the clinical trajectory of its degrader pipeline. ChartMill+2StockAnalysis+2 NRIX stock today: price
8 December 2025
·····
Carvana (CVNA) Soars on S&P 500 Inclusion: Latest News, Stock Forecast and Analysis as of December 8, 2025

Carvana (CVNA) Soars on S&P 500 Inclusion: Latest News, Stock Forecast and Analysis as of December 8, 2025

Carvana Co. (NYSE: CVNA) is back in the spotlight. On Monday, December 8, 2025, the online used-car retailer’s shares surged again after S&P Dow Jones Indices confirmed that Carvana will join the benchmark S&P 500 index on December 22, 2025. The stock traded around $454 in late session, up roughly 14% on the day and near record highs, capping a year in which the stock has gained well over 100% and staged one of the most dramatic recoveries in recent market history. Reuters According to Reuters, Carvana’s market value has swelled to roughly $87 billion, now exceeding both Ford and
8 December 2025
····
Confluent (CFLT) Soars on IBM’s $11 Billion Takeover: Deal Terms, Stock Outlook and Analyst Forecasts After December 8, 2025 Rally

Confluent (CFLT) Soars on IBM’s $11 Billion Takeover: Deal Terms, Stock Outlook and Analyst Forecasts After December 8, 2025 Rally

Confluent, Inc. (NASDAQ: CFLT) has suddenly shifted from a high-growth data‑infrastructure story to a classic M&A arbitrage play. On December 8, 2025, IBM and Confluent announced a definitive agreement under which IBM will acquire all outstanding Confluent shares for $31 in cash, valuing the data‑streaming specialist at around $11 billion enterprise value.IBM Newsroom+2ABC News+2 The news sent CFLT stock up roughly 29% in today’s session, as traders rapidly repriced the shares toward the proposed cash buyout price.MarketBeat Confluent Stock News Today: IBM Confirms $11 Billion Cash Deal IBM and Confluent jointly announced that they have entered into a definitive merger
8 December 2025
···
1 … 195 196 197 198 199 … 282

Stock Market Today

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

7 February 2026
Nvidia surged 7.8% Friday, leading a chip stock rally that pushed the Dow above 50,000 for the first time. The PHLX semiconductor index gained 5.7% as Advanced Micro Devices rose 8.3% and Broadcom 7.1%. Amazon fell 5.6% after projecting $200 billion in 2026 capital spending. Investors weighed a $600 billion AI infrastructure outlay against sharp losses in software shares.
Glencore share price steadies after Rio Tinto walks away — what to watch next week

Glencore share price steadies after Rio Tinto walks away — what to watch next week

7 February 2026
Glencore shares closed up 0.6% at 478.1 pence Friday, rebounding after a 7% drop following the collapse of merger talks with Rio Tinto. The company is expected to announce the sale of its Kazzinc stake soon and has signed a non-binding agreement with Orion for a potential $9 billion deal in the DRC. Investors await Glencore’s full-year results on Feb. 18 for further guidance.
Go toTop